The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia

Khalid Halahleh; Dalia Al Rimawi; Amal Abu Ghosh; Isra Muradi; Waleed Da’na; Mehdi Hamadani

doi:10.1016/j.hemonc.2021.07.003

Q3 2022

The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia

Khalid Halahleh · Dalia Al Rimawi · Amal Abu Ghosh · Isra Muradi · Waleed Da’na · Mehdi Hamadani

10.1016/j.hemonc.2021.07.003 390 Views 3 Citations

Citations

390

Views

Abstract not available for this publication.

Cite this Article (APA)

Khalid, H., Dalia, A. R., Amal, A. G., Isra, M., Waleed, D., Mehdi, H. (2022). The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.1016/j.hemonc.2021.07.003